Skip to main content
. Author manuscript; available in PMC: 2014 Sep 13.
Published in final edited form as: Vaccine. 2013 Jul 13;31(40):4398–4405. doi: 10.1016/j.vaccine.2013.07.003

Table 1.

Analysis of Behavioral Risk Assessment Questionnaires in HVTN Trials.

Protocol Short title Trial type
HVTN 069 Evaluation of Different Routes of Vaccine Administration Phase IB
HVTN 404 Long-term Follow-up of HIV-1 Infected Participants from Early Phase HIV Vaccine Trials or HIV Vaccine Preparedness Cohorts Roll-over/follow-up
HVTN 502 Step Study: Efficacy (Test of Concept) Study of Merck Ad5 HIV-1 Vaccine, US Phase IIB
HVTN 503 Phambili: Efficacy Study of Merck Ad5 HIV-1 Vaccine, RSA Phase IIB
HVTN 503a Feasibility Study for Recruiting Partners of HIV Vaccine Trial Participants Observational
HVTN 504 Observational Follow-up of Adult Participants enrolled in the Step Study Roll-over/follow-up
HVTN 505 Efficacy Study of VRC DNA + rAd5 HIV-1 Vaccine Phase IIB
HVTN 802 Observational Study of HIV-Infected Participants from Phase 2b-3 HIV-1 Vaccine Trials Roll-over/follow-up
HVTN 903 HIV Vaccine Preparedness Study Vaccine Preparedness
HVTN 906 Longitudinal Study of Women at High Risk for HIV-1 in the US Observational
HVTN 907 Longitudinal Study of Female Sex Workers in the Caribbean Observational